Blog
This Insurance Stock Is Down by More Than 50%. Is It a Buy?
Hippo Holdings (NYSE: HIPO) is the most successful insurance technology company so far when it comes to disrupting the legacy insurers, and it has a massive market opportunity. In this Fool Live
These 2 Top Cathie Wood Stocks That Are Better Buys Right Now Than AMC
A big trend in the stock market this year has involved so-called meme stocks. Select companies that Wall Street funds bet against as loser stocks saw their shares quickly skyrocket in price thanks
3 Cannabis Stocks That Could Make You Richer Through 2022
Some marijuana stocks seem to have already passed their peaks; others are expected to come into their own in due time. Below are three cannabis stocks that not only have good long-term prospects
Better Chinese E-Commerce Stock: Pinduoduo vs. Vipshop
Alibaba (NYSE: BABA) and JD.com (NASDAQ: JD) frequently dominate conversations about China's rapidly growing e-commerce sector.
However, investors shouldn't overlook growing underdogs like Pinduoduo
Microsoft Completed Numerous Acquisitions These Past Few Months
Today's video focuses on stock price action, valuation metrics, and recent news affecting Microsoft (NASDAQ:MSFT) and Disney (NYSE:DIS). Here are some highlights from the video.
Click the video
Should You Invest in the World's First Blockweave Crypto?
Arweave (CRYPTO: AR) is the world's first blockweave coin -- which is a data storage protocol that enables permanent storage of digital assets such as transactions, smart contracts, Web pages,
Winners and Losers From Q3's Car Chip Shortage
It's probably easier to list the industries that haven't been affected by the global computer chip shortage, but the automotive industry has been one of the most high-profile victims.
Manufacturers
Here's 1 High-Yield Dividend Stock You Can Trust
With prevailing interest rates still hovering around mid-single-digit percentages at best, income investors have been forced into stocks in search of yield. There are lots of stocks paying
1 Important Rule to Keep in Mind During Earnings Season
With quarterly earnings season coming up, get ready for an onslaught of news headlines highlighting blockbuster numbers and disappointments. However, this quarterly cadence of news can be damaging
Southwest Airlines' Flight Cancellation Problem Returns With a Vengeance
Southwest Airlines' (NYSE: LUV) summer started very poorly. The airline's operations fell into disarray beginning in mid-June, leading to thousands of flight cancellations over a period of several
4 Metrics to Use to Find Undervalued Stocks
There are many investment strategies you can adopt to help you reach your financial goals. One approach is to find fundamentally sound companies that the market has undervalued. A company's stock
3 Top Tech Stocks to Buy in October
Tech stocks took a hit earlier this year as the market moved out of some of the most popular names into more consumer cyclical stocks. The Nasdaq 100 Technology Sector index that rose 456% in 2020
I'm Buying These 3 Resilient Stocks During a Bear Market
With rising inflation, growing government debt, and concerns about how the Federal Reserve will keep the economy afloat, fears of a recession and a bear market are ever-present.
Time in the market
Why Is Everyone Talking About DatChat Stock?
DatChat (NASDAQ: DATS), which develops a privacy-oriented messaging app, went public at $4.15 per share (and one warrant for an additional share) on Aug. 12.
DatChat's stock dipped below its IPO
Should You Invest in the Virgin Orbit SPAC?
With a $6.4 billion market capitalization and shares that, despite some ups and downs, are worth 125% more today than at their 2019 IPO, space tourism company Virgin Galactic (NYSE: SPCE) is
Quarterly Earnings (10-Q) Reports: Where to Find Them and What to Look for
A public company is required to file a document disclosing financial statements and business risk every quarter with the Securities and Exchange Commission (SEC) called a 10-Q. Where can investors
It's Not Too Late to Buy This Powerful Growth Stock
It can be tempting to look past established stocks that have already delivered lots of growth in favor of newer names with loads of potential. Although that might be a valid approach sometimes, you
3 Top Healthcare Stocks to Buy Right Now
Most investors will tell you they love to buy stocks when they are cheap. But that typically means taking on some uncertainty. After all, Wall Street doesn't sell a stock unless it believes there is
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
Dividend stocks are a very helpful money-making engine that work while you're awake and while you sleep. Not only will they deliver regular income, but over time, the size of their payouts will
5 Top Tech Stocks to Buy for the Long Haul
The world we live in is more digital than ever. Technology is evolving, and traditionally non-technical industries are being infiltrated by innovation as time goes by. High-quality technology stocks
3 Biotech Stocks You Can Buy and Hold for the Next Decade
Investing in biotech companies can be hard to figure out. Great science and early-stage success doesn't always translate into drug approvals. In fact, only 10% of drug candidates that enter phase 1
3 Dividend Stocks That Had a Record Year and Are Just Getting Started
It shouldn't come as a surprise that with markets trading near all-time highs, there are well-known large cap companies also priced at, or near, record levels. But investors should realize it
Could This Stock Be a Big Winner From the U.S. Labor Shortage?
Simply put, there are more jobs right now than there are qualified workers, and this has led employers to become more competitive with one another -- not just when it comes to wages, but employee
The Pandemic Boosted a Key Piece of Oracle's Business – But Is It Sustainable?
Long-term Oracle (NYSE: ORCL) shareholders will be the first to tell you that the company's pivot into cloud-based ERP solutions wasn't always the clear way forward for the company -- though it has
2 Reasons to Buy Novavax Stock Now and 1 Reason to Skip It
It's been a harrowing quarter for Novavax (NASDAQ: NVAX) investors. The stock is down by more than 13% over the last three months, and even with approval for its coronavirus vaccine candidate


